Excelsior Medical Co Ltd (4104) - Net Assets
Based on the latest financial reports, Excelsior Medical Co Ltd (4104) has net assets worth NT$11.32 Billion TWD (≈ $356.52 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$18.80 Billion ≈ $592.39 Million USD) and total liabilities (NT$7.49 Billion ≈ $235.87 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of Excelsior Medical Co Ltd to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$11.32 Billion |
| % of Total Assets | 60.18% |
| Annual Growth Rate | 9.95% |
| 5-Year Change | 18.56% |
| 10-Year Change | 38.88% |
| Growth Volatility | 13.31 |
Excelsior Medical Co Ltd - Net Assets Trend (2002–2024)
This chart illustrates how Excelsior Medical Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of Excelsior Medical Co Ltd for the complete picture of this company's asset base.
Annual Net Assets for Excelsior Medical Co Ltd (2002–2024)
The table below shows the annual net assets of Excelsior Medical Co Ltd from 2002 to 2024. For live valuation and market cap data, see Excelsior Medical Co Ltd market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$11.36 Billion ≈ $357.82 Million |
+4.07% |
| 2023-12-31 | NT$10.91 Billion ≈ $343.82 Million |
+5.98% |
| 2022-12-31 | NT$10.30 Billion ≈ $324.42 Million |
+5.66% |
| 2021-12-31 | NT$9.75 Billion ≈ $307.04 Million |
+1.73% |
| 2020-12-31 | NT$9.58 Billion ≈ $301.81 Million |
+10.98% |
| 2019-12-31 | NT$8.63 Billion ≈ $271.95 Million |
+3.47% |
| 2018-12-31 | NT$8.34 Billion ≈ $262.83 Million |
+3.96% |
| 2017-12-31 | NT$8.02 Billion ≈ $252.83 Million |
-3.42% |
| 2016-12-31 | NT$8.31 Billion ≈ $261.77 Million |
+1.60% |
| 2015-12-31 | NT$8.18 Billion ≈ $257.65 Million |
+4.13% |
| 2014-12-31 | NT$7.85 Billion ≈ $247.44 Million |
+4.97% |
| 2013-12-31 | NT$7.48 Billion ≈ $235.72 Million |
+15.37% |
| 2012-12-31 | NT$6.49 Billion ≈ $204.31 Million |
+5.00% |
| 2011-12-31 | NT$6.18 Billion ≈ $194.58 Million |
+1.64% |
| 2010-12-31 | NT$6.08 Billion ≈ $191.44 Million |
+30.63% |
| 2009-12-31 | NT$4.65 Billion ≈ $146.56 Million |
+20.89% |
| 2008-12-31 | NT$3.85 Billion ≈ $121.23 Million |
-1.30% |
| 2007-12-31 | NT$3.90 Billion ≈ $122.83 Million |
+33.31% |
| 2006-12-31 | NT$2.92 Billion ≈ $92.14 Million |
+35.99% |
| 2005-12-31 | NT$2.15 Billion ≈ $67.75 Million |
+1.25% |
| 2004-12-31 | NT$2.12 Billion ≈ $66.92 Million |
+3.74% |
| 2003-12-31 | NT$2.05 Billion ≈ $64.51 Million |
+45.32% |
| 2002-12-31 | NT$1.41 Billion ≈ $44.39 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Excelsior Medical Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 378.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$3.62 Billion | 40.36% |
| Common Stock | NT$1.63 Billion | 18.22% |
| Other Comprehensive Income | NT$333.49 Million | 3.72% |
| Other Components | NT$3.38 Billion | 37.71% |
| Total Equity | NT$8.97 Billion | 100.00% |
Excelsior Medical Co Ltd Competitors by Market Cap
The table below lists competitors of Excelsior Medical Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
King’s Town Construction Co Ltd
TW:2524
|
$423.74 Million |
|
Emergent Biosolutions Inc
NYSE:EBS
|
$423.84 Million |
|
Suzhou Mingzhi Technology Co. Ltd. A
SHG:688355
|
$423.90 Million |
|
Wuhan Sante Cableway Group Co Ltd
SHE:002159
|
$423.94 Million |
|
NanJing Sanchao Advanced Materials Co Ltd
SHE:300554
|
$423.67 Million |
|
Beijing HuaYuanYiTong Thermal Technology Co Ltd
SHE:002893
|
$423.60 Million |
|
TARC Limited
NSE:TARC
|
$423.52 Million |
|
Blue Label Telecoms Ltd
JSE:BLU
|
$423.38 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Excelsior Medical Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 8,613,009,000 to 8,970,241,000, a change of 357,232,000 (4.1%).
- Net income of 771,259,000 contributed positively to equity growth.
- Dividend payments of 591,344,000 reduced retained earnings.
- Other comprehensive income increased equity by 66,823,999.
- Other factors increased equity by 110,493,001.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$771.26 Million | +8.6% |
| Dividends Paid | NT$591.34 Million | -6.59% |
| Other Comprehensive Income | NT$66.82 Million | +0.74% |
| Other Changes | NT$110.49 Million | +1.23% |
| Total Change | NT$- | 4.15% |
Book Value vs Market Value Analysis
This analysis compares Excelsior Medical Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.37x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.88x to 1.37x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2009-12-31 | NT$37.91 | NT$71.40 | x |
| 2010-12-31 | NT$44.27 | NT$71.40 | x |
| 2011-12-31 | NT$40.29 | NT$71.40 | x |
| 2012-12-31 | NT$42.47 | NT$71.40 | x |
| 2013-12-31 | NT$46.40 | NT$71.40 | x |
| 2014-12-31 | NT$48.83 | NT$71.40 | x |
| 2015-12-31 | NT$48.40 | NT$71.40 | x |
| 2016-12-31 | NT$45.38 | NT$71.40 | x |
| 2017-12-31 | NT$44.65 | NT$71.40 | x |
| 2018-12-31 | NT$47.91 | NT$71.40 | x |
| 2019-12-31 | NT$46.56 | NT$71.40 | x |
| 2020-12-31 | NT$46.37 | NT$71.40 | x |
| 2021-12-31 | NT$47.09 | NT$71.40 | x |
| 2022-12-31 | NT$49.93 | NT$71.40 | x |
| 2023-12-31 | NT$52.49 | NT$71.40 | x |
| 2024-12-31 | NT$52.07 | NT$71.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Excelsior Medical Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.60%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.03%
- • Asset Turnover: 0.42x
- • Equity Multiplier: 2.27x
- Recent ROE (8.60%) is below the historical average (9.17%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 20.21% | 21.92% | 0.64x | 1.45x | NT$143.86 Million |
| 2003 | 12.10% | 15.40% | 0.56x | 1.39x | NT$43.02 Million |
| 2004 | 7.05% | 7.28% | 0.52x | 1.86x | NT$-60.94 Million |
| 2005 | 11.84% | 8.42% | 0.72x | 1.95x | NT$37.49 Million |
| 2006 | 12.34% | 11.68% | 0.73x | 1.44x | NT$64.04 Million |
| 2007 | 32.67% | 39.92% | 0.65x | 1.27x | NT$839.72 Million |
| 2008 | 6.80% | 7.54% | 0.65x | 1.39x | NT$-110.33 Million |
| 2009 | 7.40% | 2.18% | 1.57x | 2.17x | NT$-109.84 Million |
| 2010 | 6.76% | 2.32% | 1.31x | 2.22x | NT$-170.24 Million |
| 2011 | 6.27% | 5.57% | 0.48x | 2.35x | NT$-198.75 Million |
| 2012 | 4.92% | 4.60% | 0.46x | 2.33x | NT$-284.82 Million |
| 2013 | 4.90% | 5.22% | 0.40x | 2.32x | NT$-312.33 Million |
| 2014 | 4.62% | 4.92% | 0.39x | 2.41x | NT$-332.07 Million |
| 2015 | 5.91% | 6.11% | 0.40x | 2.43x | NT$-262.32 Million |
| 2016 | 5.98% | 6.28% | 0.37x | 2.58x | NT$-261.70 Million |
| 2017 | 6.22% | 6.55% | 0.41x | 2.33x | NT$-242.60 Million |
| 2018 | 6.63% | 7.12% | 0.45x | 2.05x | NT$-229.12 Million |
| 2019 | 7.41% | 7.97% | 0.47x | 1.98x | NT$-179.88 Million |
| 2020 | 7.53% | 8.56% | 0.48x | 1.84x | NT$-187.42 Million |
| 2021 | 7.85% | 9.24% | 0.44x | 1.95x | NT$-166.69 Million |
| 2022 | 8.14% | 9.29% | 0.44x | 2.01x | NT$-152.59 Million |
| 2023 | 8.67% | 9.07% | 0.46x | 2.10x | NT$-114.70 Million |
| 2024 | 8.60% | 9.03% | 0.42x | 2.27x | NT$-125.77 Million |
Industry Comparison
This section compares Excelsior Medical Co Ltd's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $3,590,287,000
- Average return on equity (ROE) among peers: 6.19%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Excelsior Medical Co Ltd (4104) | NT$11.32 Billion | 20.21% | 0.66x | $423.73 Million |
| CHC Healthcare Group (4164) | $5.13 Billion | 6.30% | 1.11x | $178.76 Million |
| ShareHope Medicine Co Ltd (8403) | $2.05 Billion | 6.08% | 0.64x | $93.23 Million |
About Excelsior Medical Co Ltd
Excelsior Medical Co., Ltd., together with its subsidiaries, sells medical supplies and equipment, medicines, and home medical devices in Taiwan, Hong Kong, China, the Philippines, Malaysia, and Indonesia. It operates in four segments: Excelsior, Dynamic, Arich, and Other. The company offers hemodialysis/plasma exchange; blood bags; artificial stomas; and health appliances. It is also involved in… Read more